Moderna and Other Vaccine Stocks Climb After Coronavirus News From China
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...
Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...
Moderna fined for ‘luring children into Covid vaccine trials’ with teddy bears
Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...
Chinese researchers find bat virus enters human cells via same pathway as COVID
A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the SARS-CoV-2 virus ...
No, Moderna Did Not Create Its COVID Vaccine Two Years Before the Pandemic
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic began—proof that health authorities had planned the pandemic in advance.
Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
Moderna Inc. (NASDAQ:MRNA) reported a fourth-quarter EPS loss of $(2.91), missing the consensus of $(2.62), a turnaround from ...
Moderna beats on revenue but loses more than expected as it scales down manufacturing
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
The Financial Express27m
Coronavirus 2.0 coming soon? China discovers new virus with potential to infect humans, here’s all we know
Lab experiments showed that the virus could infect human cells with high ACE2 levels, including models of human intestines ...
Global concern grows for new pandemic after research team in China detects Covid-like virus in bats with same potential to infect humans
Researchers at the Wuhan Institute of Virology in China have discovered a new Covid-19 like virus in bats which could ...
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue ...